Your browser doesn't support javascript.
loading
Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma.
Huang, Shan-Zhou; Wei, Meng-Ning; Huang, Jia-Rong; Zhang, Zi-Jian; Zhang, Wen-Ji; Jiang, Qi-Wei; Yang, Yang; Wang, Huan-Yu; Jin, Hui-Lin; Wang, Kun; Xing, Zi-Hao; Yuan, Meng-Ling; Li, Yao; He, Xiao-Shun; Shi, Zhi; Zhou, Qi.
Affiliation
  • Huang SZ; Department of Hepatic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Wei MN; Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Huang JR; Guangdong Provincial Key Laboratory of Bioengineering Medicine, Department of Cell Biology and Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Zhang ZJ; Guangdong Provincial Key Laboratory of Bioengineering Medicine, Department of Cell Biology and Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Zhang WJ; Department of Hepatobiliary Surgery, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
  • Jiang QW; Guangdong Provincial Key Laboratory of Bioengineering Medicine, Department of Cell Biology and Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Yang Y; Guangdong Provincial Key Laboratory of Bioengineering Medicine, Department of Cell Biology and Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Wang HY; Guangdong Provincial Key Laboratory of Bioengineering Medicine, Department of Cell Biology and Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Jin HL; Department of Thyroid and Breast Surgery, Nanshan District People's Hospital, Shenzhen, China.
  • Wang K; Department of Hepatic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Xing ZH; Guangdong Provincial Key Laboratory of Bioengineering Medicine, Department of Cell Biology and Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Yuan ML; Guangdong Provincial Key Laboratory of Bioengineering Medicine, Department of Cell Biology and Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Li Y; Guangdong Provincial Key Laboratory of Bioengineering Medicine, Department of Cell Biology and Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • He XS; Guangdong Provincial Key Laboratory of Bioengineering Medicine, Department of Cell Biology and Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Shi Z; Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zhou Q; Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Front Oncol ; 9: 150, 2019.
Article in En | MEDLINE | ID: mdl-30931258

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2019 Document type: Article Affiliation country: China Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2019 Document type: Article Affiliation country: China Country of publication: Suiza